Patterns of Care and Clinical Outcomes with 7 + 3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Population-Based Study
Amer M. Zeidan 1, 2, Nikolai A. Podoltsev2, 3, Xiaoyi Wang2,4, et al.
1 Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA
2 Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA
3 Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT, USA
4 Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT, USA
Program: Oral and Poster Abstracts Type: Oral Session: 615. Acute Myeloid Leukemia: Commercially Available Therapy, Excluding Transplantation: Induction and Post-Remission Therapy Hematology Disease Topics & Pathways: Diseases, AML, Adult, Therapies, Non-Biological, Chemotherapy, Study Population, Myeloid Malignancies, Quality Improvement Saturday, December 7, 2019: 9:45 AM W304, Level 3 (Orange County Convention Center) ...